Device approvals, acquisitions & more — 3 GI company key notes

Here are three updates on GI companies from the past week:

Mallinckrodt will acquire Sucampo Pharmaceuticals' commercial and development assets for approximately $1.2 billion, pending regulatory approval.

Recent SEC filings provided insights into Exact Sciences, the company that manufactures Cologuard, finding President and CEO Kevin Conroy sold 245,362 shares for a total of $13 million.

Pentax Medical launched its C.A.P. HD Duodenoscope in the U.S.; it is the first duodenoscope with a disposable distal cap.

More articles on gastroenterology:
Mallinckrodt acquiring Sucampo Pharmaceuticals for $1.2B — 4 insights
Exact Sciences CEO sells $6.5M — Hedge funds hold 84.5% of company: 4 insights
GI leader to know: Dr. Arthur Berman of Florida Center for Gastroenterology

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers